TOKAI (9729) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
13 Jun, 2025Executive summary
Net sales for the six months ended September 30, 2024, rose 7.2% year-over-year to ¥72,725 million, marking a record high, driven by rental sales, hotel linen supply growth, and a new subsidiary.
Operating profit was nearly flat at ¥3,664 million, down 0.6% year-over-year, due to higher depreciation and increased costs in Pharmacy Services.
Profit attributable to owners of parent increased 15.8% to ¥3,041 million, with basic earnings per share rising to ¥88.82 from ¥74.62.
Financial highlights
Gross profit for the period was ¥16,990 million, up from ¥16,463 million year-over-year.
Ordinary profit increased 1.3% to ¥3,917 million year-over-year.
Comprehensive income declined to ¥2,305 million from ¥3,172 million year-over-year.
Total assets as of September 30, 2024, were ¥112,406 million, with a capital adequacy ratio of 75.1%.
Net assets stood at ¥85,055 million, down from ¥86,789 million at the previous fiscal year-end.
Outlook and guidance
Full-year net sales forecast is ¥142,925 million, up 3.4% year-over-year, with operating profit expected to decline 4.8% to ¥7,695 million.
Profit attributable to owners of parent is projected at ¥5,578 million, down 4.0%, and basic earnings per share forecast is ¥158.51.
Forecasts and forward-looking statements are subject to risks and uncertainties, and actual results may differ.
Latest events from TOKAI
- Record sales and profit growth, driven by rental, pharmacy, M&A, and special dividends.9729
Q3 202612 Feb 2026 - Record sales and profit growth, higher dividends, and capital returns planned.9729
Q2 202611 Nov 2025 - Record sales and operating profit, but net profit fell; outlook and dividend raised.9729
Q1 20267 Aug 2025 - Sales and profits rose, with strong Q1 gains and stable full-year outlook.9729
Q1 202513 Jun 2025 - Record sales and profit growth, but net income fell on impairments; outlook remains positive.9729
Q4 20256 Jun 2025 - Record sales growth, but profit pressured by higher costs and securities losses.9729
Q3 20255 Jun 2025